Acute pharmacologic blockade of dyskinesias in Parkinson's disease
- 1 September 1996
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 11 (5) , 580-581
- https://doi.org/10.1002/mds.870110516
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Suppression of Levodopa‐Induced Dyskinesias by an NMDA Receptor Antagonist in MPTP‐Treated MonkeysNeurology, 1995
- Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' diseaseSynapse, 1995
- Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's diseaseAnnals of Neurology, 1994
- Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned ratsNeuroscience, 1994
- Apomorphine-induced changes in striatal and pallidal neuronal activity are modified by NMDA and muscarinic receptor blockadeLife Sciences, 1992
- The competitive NMDA antagonist CGP40.116 enhances L-DOPA response in MPTP-treated marmosetsNeuropharmacology, 1992
- Pathogenesis of dyskinesias in parkinson's diseaseAnnals of Neurology, 1989
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989